 Swati Jain
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cold Ischemia | 5 | 2021 | 40 | 1.900 |
Why?
| | Apoptosis | 7 | 2021 | 2454 | 1.630 |
Why?
| | Kidney Transplantation | 8 | 2025 | 732 | 1.550 |
Why?
| | Kidney Tubules | 3 | 2016 | 118 | 1.280 |
Why?
| | Acute Kidney Injury | 4 | 2022 | 880 | 1.230 |
Why?
| | Organ Preservation | 3 | 2018 | 127 | 0.940 |
Why?
| | Necrosis | 3 | 2021 | 245 | 0.940 |
Why?
| | Rewarming | 2 | 2016 | 22 | 0.890 |
Why?
| | Hibernation | 4 | 2026 | 82 | 0.850 |
Why?
| | Dermatitis | 1 | 2024 | 20 | 0.820 |
Why?
| | AIDS Vaccines | 1 | 2024 | 53 | 0.800 |
Why?
| | Reperfusion Injury | 3 | 2026 | 294 | 0.760 |
Why?
| | Caspase 1 | 2 | 2021 | 145 | 0.740 |
Why?
| | Caspase 3 | 4 | 2018 | 242 | 0.670 |
Why?
| | Sciuridae | 3 | 2026 | 152 | 0.650 |
Why?
| | Caspase Inhibitors | 2 | 2018 | 81 | 0.580 |
Why?
| | Toll-Like Receptor 4 | 1 | 2021 | 277 | 0.580 |
Why?
| | Inhibitor of Apoptosis Proteins | 2 | 2016 | 46 | 0.580 |
Why?
| | Kidney | 7 | 2026 | 1511 | 0.570 |
Why?
| | HIV-1 | 1 | 2024 | 917 | 0.520 |
Why?
| | Thiones | 1 | 2015 | 13 | 0.460 |
Why?
| | Pyrimidinones | 1 | 2015 | 125 | 0.430 |
Why?
| | Cold Temperature | 1 | 2016 | 207 | 0.420 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2016 | 440 | 0.390 |
Why?
| | Autophagy | 1 | 2014 | 291 | 0.350 |
Why?
| | Mice, Inbred C57BL | 7 | 2021 | 6042 | 0.330 |
Why?
| | Proteins | 1 | 2017 | 1024 | 0.330 |
Why?
| | Animals | 16 | 2026 | 38417 | 0.300 |
Why?
| | Algorithms | 1 | 2017 | 1868 | 0.280 |
Why?
| | Mice | 9 | 2024 | 18493 | 0.280 |
Why?
| | Carbapenem-Resistant Enterobacteriaceae | 1 | 2026 | 4 | 0.240 |
Why?
| | Delayed Graft Function | 2 | 2018 | 54 | 0.240 |
Why?
| | beta-Lactamases | 1 | 2026 | 54 | 0.230 |
Why?
| | Enterobacteriaceae Infections | 1 | 2026 | 43 | 0.230 |
Why?
| | Antigens, Viral | 1 | 2024 | 186 | 0.190 |
Why?
| | Antibody Formation | 1 | 2024 | 288 | 0.190 |
Why?
| | Swine | 2 | 2015 | 828 | 0.180 |
Why?
| | Tissue Donors | 2 | 2025 | 427 | 0.180 |
Why?
| | Antibodies | 1 | 2024 | 398 | 0.170 |
Why?
| | Models, Animal | 2 | 2020 | 394 | 0.170 |
Why?
| | Peritoneal Dialysis | 1 | 2022 | 100 | 0.170 |
Why?
| | Warm Ischemia | 1 | 2020 | 28 | 0.160 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 80 | 0.160 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 56 | 0.160 |
Why?
| | Signal Transduction | 3 | 2021 | 5272 | 0.150 |
Why?
| | Bacterial Proteins | 1 | 2026 | 977 | 0.150 |
Why?
| | Adipocytes | 1 | 2020 | 223 | 0.140 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 2018 | 24 | 0.140 |
Why?
| | Vitamin D Deficiency | 1 | 2020 | 190 | 0.140 |
Why?
| | Organ Preservation Solutions | 1 | 2018 | 46 | 0.140 |
Why?
| | Nephrectomy | 2 | 2018 | 172 | 0.140 |
Why?
| | Cells, Cultured | 2 | 2016 | 4170 | 0.130 |
Why?
| | Mice, Knockout | 2 | 2021 | 3153 | 0.130 |
Why?
| | Quinolines | 1 | 2018 | 192 | 0.130 |
Why?
| | Computer Graphics | 1 | 2017 | 41 | 0.120 |
Why?
| | Longitudinal Studies | 1 | 2024 | 3029 | 0.120 |
Why?
| | LLC-PK1 Cells | 1 | 2015 | 18 | 0.120 |
Why?
| | Protein Engineering | 1 | 2017 | 122 | 0.120 |
Why?
| | Cytoprotection | 1 | 2015 | 56 | 0.110 |
Why?
| | Arteriovenous Anastomosis | 1 | 2015 | 13 | 0.110 |
Why?
| | Biomarkers | 2 | 2025 | 4354 | 0.110 |
Why?
| | AMP Deaminase | 1 | 2015 | 11 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2026 | 1940 | 0.110 |
Why?
| | Renal Artery | 1 | 2015 | 43 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2015 | 52 | 0.110 |
Why?
| | Vascular Surgical Procedures | 2 | 2015 | 347 | 0.110 |
Why?
| | Male | 10 | 2026 | 73954 | 0.110 |
Why?
| | Adipose Tissue | 2 | 2020 | 646 | 0.110 |
Why?
| | Thermodynamics | 1 | 2017 | 420 | 0.110 |
Why?
| | Microsurgery | 1 | 2015 | 76 | 0.110 |
Why?
| | Species Specificity | 1 | 2016 | 547 | 0.110 |
Why?
| | Macrolides | 1 | 2014 | 68 | 0.100 |
Why?
| | RNA Interference | 1 | 2016 | 477 | 0.100 |
Why?
| | Aging | 1 | 2025 | 1992 | 0.100 |
Why?
| | Protein Conformation | 1 | 2017 | 943 | 0.100 |
Why?
| | Transfection | 1 | 2016 | 930 | 0.100 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2015 | 192 | 0.100 |
Why?
| | Renin-Angiotensin System | 1 | 2013 | 80 | 0.100 |
Why?
| | Amino Acid Sequence | 1 | 2017 | 2134 | 0.090 |
Why?
| | Computational Biology | 1 | 2017 | 677 | 0.090 |
Why?
| | Models, Molecular | 1 | 2017 | 1606 | 0.090 |
Why?
| | Software | 1 | 2017 | 683 | 0.090 |
Why?
| | Phosphorylation | 1 | 2016 | 1721 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4605 | 0.080 |
Why?
| | Adaptation, Physiological | 1 | 2013 | 568 | 0.070 |
Why?
| | Seasons | 2 | 2026 | 540 | 0.070 |
Why?
| | Epithelial Cells | 1 | 2014 | 1141 | 0.070 |
Why?
| | Creatinine | 2 | 2020 | 516 | 0.060 |
Why?
| | Heterocyclic Compounds, 1-Ring | 1 | 2026 | 7 | 0.060 |
Why?
| | Azabicyclo Compounds | 1 | 2026 | 8 | 0.060 |
Why?
| | Ceftazidime | 1 | 2026 | 8 | 0.060 |
Why?
| | Aztreonam | 1 | 2026 | 12 | 0.060 |
Why?
| | Humans | 8 | 2026 | 147306 | 0.060 |
Why?
| | Carbapenems | 1 | 2026 | 28 | 0.060 |
Why?
| | Boronic Acids | 1 | 2026 | 37 | 0.060 |
Why?
| | Torpor | 1 | 2026 | 19 | 0.060 |
Why?
| | Reperfusion | 1 | 2026 | 54 | 0.060 |
Why?
| | Klebsiella pneumoniae | 1 | 2026 | 48 | 0.060 |
Why?
| | Arousal | 1 | 2026 | 158 | 0.060 |
Why?
| | United Kingdom | 1 | 2026 | 391 | 0.050 |
Why?
| | Drug Combinations | 1 | 2026 | 399 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2026 | 367 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 347 | 0.050 |
Why?
| | New York City | 1 | 2022 | 87 | 0.050 |
Why?
| | Glucose | 2 | 2020 | 1051 | 0.050 |
Why?
| | Escherichia coli | 1 | 2026 | 836 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2025 | 765 | 0.040 |
Why?
| | Liver | 2 | 2020 | 1916 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 267 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2022 | 467 | 0.030 |
Why?
| | Ischemia | 1 | 2020 | 424 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3372 | 0.030 |
Why?
| | Vitamin D | 1 | 2020 | 405 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2025 | 11947 | 0.030 |
Why?
| | Overweight | 1 | 2020 | 617 | 0.030 |
Why?
| | Renal Artery Obstruction | 1 | 2015 | 30 | 0.030 |
Why?
| | Transplants | 1 | 2015 | 38 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2025 | 17561 | 0.030 |
Why?
| | Renal Circulation | 1 | 2015 | 75 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2015 | 167 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1720 | 0.020 |
Why?
| | Aged | 2 | 2025 | 26516 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2832 | 0.020 |
Why?
| | Macrophages | 1 | 2020 | 1530 | 0.020 |
Why?
| | Body Temperature | 1 | 2013 | 229 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2020 | 1253 | 0.020 |
Why?
| | Fatty Acids | 1 | 2015 | 461 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2015 | 1077 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2015 | 538 | 0.020 |
Why?
| | Thrombosis | 1 | 2015 | 401 | 0.020 |
Why?
| | Infant | 1 | 2025 | 10195 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1127 | 0.020 |
Why?
| | Female | 3 | 2025 | 80081 | 0.020 |
Why?
| | Child, Preschool | 1 | 2025 | 12017 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2526 | 0.020 |
Why?
| | Adult | 2 | 2025 | 41406 | 0.020 |
Why?
| | Middle Aged | 2 | 2022 | 36821 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2921 | 0.020 |
Why?
| | Obesity | 1 | 2020 | 3149 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22826 | 0.010 |
Why?
| | Child | 1 | 2025 | 22980 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2015 | 3022 | 0.010 |
Why?
|
|
Jain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|